| scholarly article | Q13442814 |
| P50 | author | Gregory S Karczmar | Q89851708 |
| P2093 | author name string | Cheng Yang | |
| Masoom A Haider | |||
| Walter M Stadler | |||
| Ivan Yeung | |||
| Michael Milosevic | |||
| P2860 | cites work | Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 |
| Gd-DTPA relaxivity depends on macromolecular content | Q30619373 | ||
| Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. | Q33744660 | ||
| Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? | Q34629116 | ||
| Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions | Q34918635 | ||
| Perfusion CT: a worthwhile enhancement? | Q35113503 | ||
| Correlation and simple linear regression | Q35139581 | ||
| Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations | Q36056383 | ||
| The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. | Q36616812 | ||
| Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. | Q36729234 | ||
| Strategic approach to fit-for-purpose biomarkers in drug development | Q36971800 | ||
| Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer | Q37219981 | ||
| Validation of analytic methods for biomarkers used in drug development | Q37284255 | ||
| Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma | Q37331117 | ||
| Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis | Q42000157 | ||
| Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent | Q42622156 | ||
| Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules | Q43690597 | ||
| Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a | Q44601128 | ||
| Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study | Q44939902 | ||
| Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents | Q46450193 | ||
| Validation of the use of calibration factors between the iodine concentration and the computed tomography number measured outside the objects for estimation of iodine concentration inside the objects: phantom experiment | Q46569840 | ||
| Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time | Q47279280 | ||
| Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts | Q48797418 | ||
| Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. | Q51120063 | ||
| Inflow effect correction in fast gradient-echo perfusion imaging. | Q51805187 | ||
| Multiple reference tissue method for contrast agent arterial input function estimation. | Q51902118 | ||
| A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. | Q53443105 | ||
| Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients. | Q53549709 | ||
| Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. | Q53618262 | ||
| Functional CT imaging in oncology. | Q53630387 | ||
| CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience | Q56786000 | ||
| Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements | Q57617810 | ||
| Cardiac flow measurement by ultrafast CT: validation of continuous and pulsatile flow | Q68040932 | ||
| Human pharmacokinetics of iohexol. A new nonionic contrast medium | Q70437566 | ||
| Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers | Q70685636 | ||
| Inflow effect in first-pass cardiac and renal MRI | Q73851893 | ||
| Gadolinium as a CT contrast agent: assessment in a porcine model | Q77337477 | ||
| Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience | Q77785612 | ||
| Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations | Q80914940 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| P304 | page(s) | 1601-1609 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Magnetic Resonance in Medicine | Q6731496 |
| P1476 | title | Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. | |
| P478 | volume | 63 |
| Q53113924 | A comparison of dynamic contrast-enhanced CT and MR imaging-derived measurements in patients with cervical cancer. |
| Q37662706 | A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation. |
| Q31053409 | Are complex DCE-MRI models supported by clinical data? |
| Q47568614 | Comparison of arterial input functions measured from ultra-fast dynamic contrast enhanced MRI and dynamic contrast enhanced computed tomography in prostate cancer patients |
| Q49052819 | First order correction for T2*-relaxation in determining contrast agent concentration from spoiled gradient echo pulse sequence signal intensity. |
| Q34040125 | Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI. |
| Q38643119 | Hypoxia in cervical cancer: from biology to imaging |
| Q40128427 | Improved accuracy of quantitative parameter estimates in dynamic contrast-enhanced CT study with low temporal resolution. |
| Q38282639 | Models and methods for analyzing DCE-MRI: a review. |
| Q46265644 | On the scope and interpretation of the Tofts models for DCE-MRI. |
| Q53223640 | Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT. |
| Q37789105 | Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR Imaging |
| Q50754613 | Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study. |
| Q37871859 | Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review |
| Q26743358 | Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images |
| Q26865378 | Radiomics: the process and the challenges |
| Q39651262 | Reference region-based pharmacokinetic modeling in quantitative dynamic contract-enhanced MRI allows robust treatment monitoring in a rat liver tumor model despite cardiovascular changes. |
| Q33647695 | The use of a reference tissue arterial input function with low-temporal-resolution DCE-MRI data |
| Q64968276 | Use of Indicator Dilution Principle to Evaluate Accuracy of Arterial Input Function Measured With Low-Dose Ultrafast Prostate Dynamic Contrast-Enhanced MRI. |
| Q53096620 | Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer. |
Search more.